Jamison, PA, United States of America

Aihua Wang

USPTO Granted Patents = 51 

 

 

Average Co-Inventor Count = 6.5

ph-index = 9

Forward Citations = 299(Granted Patents)

Forward Citations (Not Self Cited) = 214(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Downingtown, PA (US) (2001)
  • Jamison, PA (US) (2002 - 2023)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
51 patents (USPTO):

Title: Aihua Wang: Innovator in JAK Kinase Inhibitors

Introduction: Aihua Wang, based in Jamison, PA, is an accomplished inventor with a remarkable portfolio of 51 patents. His innovative work primarily focuses on small molecule inhibitors targeting the JAK family of kinases, which play a significant role in various disease mechanisms. Wang's contributions to pharmaceutical compositions have made notable advancements in treating inflammatory diseases.

Latest Patents: Among Wang's latest patents are "Small molecule inhibitors of the JAK family of kinases" and "Imidazopyrrolopyridine as inhibitors of the JAK family of kinases." These inventions include 2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, which are essential for pharmaceutical compositions intended for the treatment of diseases linked to JAK, such as inflammatory bowel disease. These patents highlight his commitment to advancing healthcare through innovative medicinal solutions.

Career Highlights: Aihua Wang has made significant strides in his career, having worked with esteemed companies like Janssen Pharmaceutica NV and 3-Dimensional Pharmaceuticals, Inc. His expertise and contributions in these high-profile settings have played a critical role in driving forward pharmaceutical research and drug development.

Collaborations: Throughout his career, Wang has collaborated with distinguished professionals, including Gee-Hong Kuo and Kristi A. Leonard. These partnerships have fostered a productive environment for research and innovation, enhancing the development of effective treatments for complex health conditions.

Conclusion: Aihua Wang's contributions to the field of pharmacology and his extensive patent portfolio underscore his role as a leading inventor in the development of JAK kinase inhibitors. His work continues to pave the way for advancements in treatments for inflammatory diseases, affirming his status as a key innovator in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…